Clinical Trial Update: Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating pembrolizumab plus decitabine, with or without venetoclax, for patients with acute myeloid leukemia or myelodysplastic syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Dacogen) (decitabine)
• Pembrolizumab (Keytruda) (pembrolizumab)
• Venetoclax (Venclexta) (venetoclax)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | Status: RECRUITING